We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+7.47%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$15.3B
AUM Growth
+$2.76B
(+22%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
12.55%
Top 10 Holdings %
Top 10 Hldgs %
45.98%
Holding
1,005
New
144
Increased
321
Reduced
458
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$335M |
| 2 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$122M |
| 3 |
JPMorgan Chase
JPM
|
+$113M |
| 4 |
Cheniere Energy
CQP
|
+$111M |
| 5 |
ENBL
ENABLE MIDSTREAM PARTNERS, LP
ENBL
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DM
Dominion Energy Midstream Ptr LP
DM
|
+$55.1M |
| 2 |
Navient
NAVI
|
+$47.5M |
| 3 |
Macy's
M
|
+$17.7M |
| 4 |
Occidental Petroleum
OXY
|
+$17M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 54.25% |
| 2 | Financials | 6.56% |
| 3 | Healthcare | 3.56% |
| 4 | Consumer Discretionary | 2.58% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNR
351
DELISTED
Denbury Resources, Inc.
DNR
| $920K | 0.01% |
191,321
-9,004
| -4% | -$33.8K |
|
352
FedEx
FDX
$74.5B
| $918K | 0.01% |
4,042
+941
| +30% | +$233K |
|
353
Voyager Therapeutics
VYGR
$187M
| $916K | 0.01% |
+46,900
| New | +$927K |
|
354
Duke Energy
DUK
$102B
| $914K | 0.01% |
11,563
+1,292
| +13% | +$99.4K |
|
355
Signet Jewelers
SIG
$3.55B
| $910K | 0.01% |
16,329
+5,192
| +47% | +$229K |
|
|
CNCE
356
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $901K | 0.01% |
53,536
+2,607
| +5% | +$50.6K |
|
357
Aclaris Therapeutics
ACRS
$730M
| $896K | 0.01% |
44,847
+3,478
| +8% | +$64.3K |
|
358
Capital One
COF
$124B
| $889K | 0.01% |
9,674
+774
| +9% | +$73.2K |
|
|
AGN
359
DELISTED
Allergan plc
AGN
| $884K | 0.01% |
+5,304
| New | +$852K |
|
360
Kura Oncology
KURA
$922M
| $881K | 0.01% |
48,400
+7,874
| +19% | +$133K |
|
|
NCNA
361
NuCana
NCNA
$5.37M
| $879K | 0.01% |
9
| – | – |
|
362
Dentsply Sirona
XRAY
$2.59B
| $879K | 0.01% |
+20,085
| New | +$943K |
|
363
Electronic Arts
EA
$52.4B
| $873K | 0.01% |
6,188
+1,749
| +39% | +$227K |
|
364
Fate Therapeutics
FATE
$281M
| $870K | 0.01% |
+76,714
| New | +$845K |
|
365
Cadence Design Systems
CDNS
$90B
| $868K | 0.01% |
20,045
+636
| +3% | +$26.2K |
|
|
ESV
366
DELISTED
Ensco Rowan plc
ESV
| $864K | 0.01% |
29,742
+2,786
| +10% | +$68.2K |
|
|
ODT
367
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $862K | 0.01% |
+39,022
| New | +$909K |
|
|
PGNX
368
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $860K | 0.01% |
106,983
+12,735
| +14% | +$97.2K |
|
369
Ziff Davis
ZD
$1.9B
| $859K | 0.01% |
+11,411
| New | +$836K |
|
|
PDLI
370
DELISTED
PDL BioPharma, Inc.
PDLI
| $859K | 0.01% |
367,225
+4,631
| +1% | +$12.9K |
|
371
S&P Global
SPGI
$126B
| $851K | 0.01% |
4,173
-4,840
| -54% | -$956K |
|
|
ENLC
372
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $847K | 0.01% |
51,482
-4,464
| -8% | -$71.2K |
|
373
American Electric Power
AEP
$73.7B
| $845K | 0.01% |
12,205
+5,234
| +75% | +$352K |
|
374
SunCoke Energy
SXC
$757M
| $837K | 0.01% |
62,467
+6,885
| +12% | +$85.4K |
|
|
NATI
375
DELISTED
National Instruments Corp
NATI
| $835K | 0.01% |
19,882
+539
| +3% | +$23.9K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, ALPS Advisors held 1,005 positions worth $15.3B, up 22% from $12.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
ALPS Advisors deployed $1.92B of net new capital in Q2 2018, opening 144 new positions and adding to 321 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1,144 shares worth $323M.
By sector, the portfolio is most concentrated in Energy at 54% of assets, down from 56% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dominion Energy Midstream Ptr LP, an estimated $55.1M trimmed.
- ALPS Advisors's largest Q2 2018 buy was Berkshire Hathaway Class A: 1,144 shares worth $323M.
- ALPS Advisors added most to JPMorgan Chase in Q2 2018, an estimated $113M increase.
- ALPS Advisors's biggest Q2 2018 reduction was Dominion Energy Midstream Ptr LP, cutting an estimated $55.1M.
- ALPS Advisors fully exited BeOne Medicines Ltd in Q2 2018, selling an estimated $9.35M.
- ALPS Advisors's ten largest holdings make up 46% of its $15.3B portfolio in Q2 2018.
- ALPS Advisors opened 144 new positions and closed 80 in Q2 2018.
- ALPS Advisors's portfolio value rose 22% quarter-over-quarter to $15.3B.
Based on ALPS Advisors's 13F filing for Q2 2018, filed 25 Jul 2018.